Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/ plasma carboxylesterase double knockout mice: A model for butyrylcholinesterase- deficient humans

Drug Metabolism and Disposition

Volumn 39, Issue 8, 2011, Pages 1321-1323

  Duysen, Ellen G ^a   Lockridge, Oksana ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYLCHOLINESTERASE; CARBOXYLESTERASE; CHOLINESTERASE; COCAINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BUTYLCHOLINESTERASE BLOOD LEVEL; BUTYLCHOLINESTERASE DEFICIENCY; CARBOXYLESTERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; EYE TOXICITY; GENE MUTATION; HYDROLYSIS; HYPOTHERMIA; INTOXICATION; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; BUTYRYLCHOLINESTERASE; CARBOXYLESTERASE; COCAINE; DISEASE MODELS, ANIMAL; HUMANS; MALE; METABOLISM, INBORN ERRORS; MICE; MICE, KNOCKOUT; MUTATION; TIME FACTORS;

MUS;

EID: 79960615339     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.039917     Document Type: Article

References (16)

1. Bartels CF, Jensen FS, Lockridge O, van der Spek AF, Rubinstein HM, Lubrano T, and La Du BN (1992) DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 50:1086-1103.
2. Blaho K, Logan B, Winbery S, Park L, and Schwilke E (2000) Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED. Am J Emerg Med 18:593-598.
3. Brimijoin S, Gao Y, Anker JJ, Gliddon LA, Lafleur D, Shah R, Zhao Q, Singh M, and Carroll ME (2008) A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacology 33:2715-2725.
4. Duysen EG, Li B, Carlson M, Li YF, Wieseler S, Hinrichs SH, and Lockridge O (2008) Increased hepatotoxicity and cardiac fibrosis in cocaine-treated butyrylcholinesterase knockout mice. Basic Clin Pharmacol Toxicol 103:514-521.
5. Gao Y, LaFleur D, Shah R, Zhao Q, Singh M, and Brimijoin S (2008) An albumin-butyrylcholinesterase for cocaine toxicity and addiction: catalytic and pharmacokinetic properties. Chem Biol Interact 175:83-87.
6. Hoffman RS, Henry GC, Howland MA, Weisman RS, Weil L, and Goldfrank LR (1992) Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med 21:247-253.
7. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
8. Karch SB, Stephens B, and Ho CH (1998) Relating cocaine blood concentrations to toxicity - an autopsy study of 99 cases. J Forensic Sci 43:41-45. (Pubitemid 28063703)
9. Li B, Duysen EG, Carlson M, and Lockridge O (2008) The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency. J Pharmacol Exp Ther 324:1146-1154. (Pubitemid 351397863)
10. Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, and Lockridge O (2005) Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol 70:1673-1684. (Pubitemid 41540360)
11. Lockridge O (1990) Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 47:35-60.
12. Morse AC, Erwin VG, and Jones BC (1995) Pharmacogenetics of cocaine: a critical review. Pharmacogenetics 5:183-192.
13. Om A, Ellahham S, Ornato JP, Picone C, Theogaraj J, Corretjer GP, and Vetrovec GW (1993) Medical complications of cocaine: possible relationship to low plasma cholinesterase enzyme. Am Heart J 125:1114-1117. (Pubitemid 23117346)
14. Pellinen P, Kulmala L, Konttila J, Auriola S, Pasanen M, and Juvonen R (2000) Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes. Arch Toxicol 74:511-520.
15. Redinbo MR, Bencharit S, and Potter PM (2003) Human carboxylesterase 1: from drug metabolism to drug discovery. Biochem Soc Trans 31:620-624. (Pubitemid 36750742)
16. Xie W, Altamirano CV, Bartels CF, Speirs RJ, Cashman JR, and Lockridge O (1999) An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient. Mol Pharmacol 55:83-91. (Pubitemid 29042525)